AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:AMN • US0017441017

20.3 USD
-0.55 (-2.64%)
At close: Feb 6, 2026
20.3 USD
0 (0%)
After Hours: 2/6/2026, 8:17:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AMN. AMN was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of AMN get a neutral evaluation. Nothing too spectacular is happening here. AMN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • AMN had positive earnings in the past year.
  • AMN had a positive operating cash flow in the past year.
  • AMN had positive earnings in 4 of the past 5 years.
  • In the past 5 years AMN always reported a positive cash flow from operatings.
AMN Yearly Net Income VS EBIT VS OCF VS FCFAMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • AMN has a worse Return On Assets (-12.88%) than 75.49% of its industry peers.
  • AMN has a worse Return On Equity (-42.76%) than 71.57% of its industry peers.
  • With a Return On Invested Capital value of 2.08%, AMN perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
  • AMN had an Average Return On Invested Capital over the past 3 years of 13.14%. This is above the industry average of 9.16%.
  • The last Return On Invested Capital (2.08%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
Industry RankSector Rank
ROA -12.88%
ROE -42.76%
ROIC 2.08%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
AMN Yearly ROA, ROE, ROICAMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • With a Operating Margin value of 1.65%, AMN perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AMN has declined.
  • AMN has a Gross Margin (29.37%) which is comparable to the rest of the industry.
  • AMN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.65%
PM (TTM) N/A
GM 29.37%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
AMN Yearly Profit, Operating, Gross MarginsAMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMN is creating some value.
  • AMN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AMN has less shares outstanding
  • AMN has a better debt/assets ratio than last year.
AMN Yearly Shares OutstandingAMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AMN Yearly Total Debt VS Total AssetsAMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • AMN has an Altman-Z score of 2.47. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • AMN has a Altman-Z score of 2.47. This is comparable to the rest of the industry: AMN outperforms 56.86% of its industry peers.
  • The Debt to FCF ratio of AMN is 3.80, which is a good value as it means it would take AMN, 3.80 years of fcf income to pay off all of its debts.
  • AMN has a better Debt to FCF ratio (3.80) than 72.55% of its industry peers.
  • AMN has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
  • AMN's Debt to Equity ratio of 1.31 is on the low side compared to the rest of the industry. AMN is outperformed by 65.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.8
Altman-Z 2.47
ROIC/WACC0.27
WACC7.85%
AMN Yearly LT Debt VS Equity VS FCFAMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • AMN has a Current Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of AMN (1.05) is worse than 67.65% of its industry peers.
  • AMN has a Quick Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.05, AMN is doing worse than 61.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
AMN Yearly Current Assets VS Current LiabilitesAMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.29%.
  • The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
  • The Revenue for AMN has decreased by -11.42% in the past year. This is quite bad
  • AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%

3.2 Future

  • AMN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.82% yearly.
  • Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y-57.99%
EPS Next 2Y-52.77%
EPS Next 3Y-29.64%
EPS Next 5Y22.82%
Revenue Next Year-8.07%
Revenue Next 2Y-6.86%
Revenue Next 3Y-3.35%
Revenue Next 5Y4.4%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMN Yearly Revenue VS EstimatesAMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
AMN Yearly EPS VS EstimatesAMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • AMN is valuated reasonably with a Price/Earnings ratio of 10.74.
  • Based on the Price/Earnings ratio, AMN is valued cheaply inside the industry as 87.25% of the companies are valued more expensively.
  • AMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.92.
  • With a Price/Forward Earnings ratio of 27.49, AMN can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AMN is on the same level as its industry peers.
  • AMN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.74
Fwd PE 27.49
AMN Price Earnings VS Forward Price EarningsAMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 79.41% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
  • AMN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMN is cheaper than 98.04% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.5
EV/EBITDA 7.75
AMN Per share dataAMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • AMN's earnings are expected to decrease with -29.64% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)13.35
EPS Next 2Y-52.77%
EPS Next 3Y-29.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for AMN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMN HEALTHCARE SERVICES INC

NYSE:AMN (2/6/2026, 8:17:44 PM)

After market: 20.3 0 (0%)

20.3

-0.55 (-2.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)02-19
Inst Owners109.44%
Inst Owner Change-3.26%
Ins Owners0.45%
Ins Owner Change9.04%
Market Cap779.72M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target20.84 (2.66%)
Short Float %6.27%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)0%
PT rev (3m)-0.69%
EPS NQ rev (1m)2.3%
EPS NQ rev (3m)49.55%
EPS NY rev (1m)0%
EPS NY rev (3m)20.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)16.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.59%
Valuation
Industry RankSector Rank
PE 10.74
Fwd PE 27.49
P/S 0.29
P/FCF 3.5
P/OCF 2.92
P/B 1.21
P/tB N/A
EV/EBITDA 7.75
EPS(TTM)1.89
EY9.31%
EPS(NY)0.74
Fwd EY3.64%
FCF(TTM)5.8
FCFY28.57%
OCF(TTM)6.94
OCFY34.2%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)13.35
Graham Number26.71
Profitability
Industry RankSector Rank
ROA -12.88%
ROE -42.76%
ROCE 2.81%
ROIC 2.08%
ROICexc 2.16%
ROICexgc 6.84%
OM 1.65%
PM (TTM) N/A
GM 29.37%
FCFM 8.2%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.8
Debt/EBITDA 4.12
Cap/Depr 27.3%
Cap/Sales 1.62%
Interest Coverage 0.95
Cash Conversion 129.62%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 2.47
F-Score4
WACC7.85%
ROIC/WACC0.27
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-57.99%
EPS Next 2Y-52.77%
EPS Next 3Y-29.64%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-8.07%
Revenue Next 2Y-6.86%
Revenue Next 3Y-3.35%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year103.44%
EBIT Next 3Y20.38%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%

AMN HEALTHCARE SERVICES INC / AMN FAQ

What is the fundamental rating for AMN stock?

ChartMill assigns a fundamental rating of 4 / 10 to AMN.


Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?

ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.


How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?

AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.


What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?

The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to decline by -57.99% in the next year.